|
NEIL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71918035363205E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.775990E-04 |
| Normal-vs-Stage2 |
8.644700E-04 |
| Normal-vs-Stage3 |
3.224100E-04 |
| Normal-vs-Stage4 |
2.781800E-02 |
| Stage1-vs-Stage2 |
8.290800E-01 |
| Stage1-vs-Stage3 |
8.764600E-03 |
| Stage1-vs-Stage4 |
5.094100E-02 |
| Stage2-vs-Stage3 |
1.146170E-02 |
| Stage2-vs-Stage4 |
5.354200E-02 |
| Stage3-vs-Stage4 |
2.137400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34019995101653E-09 |
| Normal-vs-AfricanAmerican |
1.01190000001417E-06 |
| Normal-vs-Asian |
1.358770E-01 |
| Caucasian-vs-AfricanAmerican |
1.183590E-03 |
| Caucasian-vs-Asian |
5.832200E-01 |
| AfricanAmerican-vs-Asian |
2.546400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00479999876057E-08 |
| Normal-vs-Female |
3.85150000000722E-05 |
| Male-vs-Female |
1.325010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.840900E-03 |
| Normal-vs-Extreme_Weight |
2.79020000004682E-06 |
| Normal-vs-Obese |
1.777830E-04 |
| Normal-vs-Extreme_Obese |
4.645800E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.096100E-02 |
| Normal_Weight-vs-Obese |
2.354200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.472400E-02 |
| Extreme_Weight-vs-Obese |
2.475400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.566400E-01 |
| Obese-vs-Extreme_Obese |
1.980180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.080100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.90820000000036E-05 |
| Normal-vs-Age(61-80Yrs) |
9.57229999709597E-08 |
| Normal-vs-Age(81-100Yrs) |
1.176430E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.398400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.676000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.836000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.682950E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.392400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.225600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.8247999999943E-06 |
| Normal-VS-Type2 PRCC |
4.64249999998501E-06 |
| Normal-VS-KIRP CIMP |
7.825800E-02 |
| Normal-VS-Unclassified PRCC |
2.05949999999566E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.180680E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.474030E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.140250E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.454000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.589900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.334200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.443600E-04 |
| Normal-vs-N1 |
7.574200E-04 |
| Normal-vs-N2 |
6.902400E-02 |
| N0-vs-N1 |
2.043900E-02 |
| N0-vs-N2 |
4.782100E-02 |
| N1-vs-N2 |
9.623000E-01 |
|
|
